133 related articles for article (PubMed ID: 17216639)
1. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Toft M; Mata IF; Ross OA; Kachergus J; Hulihan MM; Haugarvoll K; Stone JT; Blazquez M; Gibson JM; Aasly JO; White LR; Lynch T; Adler CH; Gwinn-Hardy K; Farrer MJ
Mov Disord; 2007 Feb; 22(3):389-92. PubMed ID: 17216639
[TBL] [Abstract][Full Text] [Related]
2. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
Nichols WC; Marek DK; Pauciulo MW; Pankratz N; Halter CA; Rudolph A; Shults CW; Wojcieszek J; Foroud T;
Mov Disord; 2007 Jan; 22(2):254-7. PubMed ID: 17149721
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.
Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A
Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
[TBL] [Abstract][Full Text] [Related]
5. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
[TBL] [Abstract][Full Text] [Related]
6. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred].
Miranda M
Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590
[No Abstract] [Full Text] [Related]
7. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
[TBL] [Abstract][Full Text] [Related]
8. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.
Bras JM; Guerreiro RJ; Ribeiro MH; Januario C; Morgadinho A; Oliveira CR; Cunha L; Hardy J; Singleton A
Mov Disord; 2005 Dec; 20(12):1653-5. PubMed ID: 16149095
[TBL] [Abstract][Full Text] [Related]
9. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
[TBL] [Abstract][Full Text] [Related]
10. The biology and pathobiology of LRRK2: implications for Parkinson's disease.
Moore DJ
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.
Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S
Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768
[TBL] [Abstract][Full Text] [Related]
12. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
[TBL] [Abstract][Full Text] [Related]
13. Mutations in LRRK2 as a cause of Parkinson's disease.
Giasson BI; Van Deerlin VM
Neurosignals; 2008; 16(1):99-105. PubMed ID: 18097165
[TBL] [Abstract][Full Text] [Related]
14. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].
Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
16. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).
Ruiz-Martínez J; Gorostidi A; Ibañez B; Alzualde A; Otaegui D; Moreno F; López de Munain A; Bergareche A; Gómez-Esteban JC; Martí Massó JF
Mov Disord; 2010 Oct; 25(14):2340-5. PubMed ID: 20721916
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of LRRK2 functional domains in Brazilian patients with Parkinson's disease.
Abdalla-Carvalho CB; Santos-Rebouças CB; Guimarães BC; Campos M; Pereira JS; de Rosso AL; Nicaretta DH; Marinho e Silva M; dos Santos MJ; Pimentel MM
Eur J Neurol; 2010 Dec; 17(12):1479-81. PubMed ID: 20443975
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
Krüger R
BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509
[TBL] [Abstract][Full Text] [Related]
20. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.
Farrer MJ; Stone JT; Lin CH; Dächsel JC; Hulihan MM; Haugarvoll K; Ross OA; Wu RM
Parkinsonism Relat Disord; 2007 Mar; 13(2):89-92. PubMed ID: 17222580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
